Cargando…
Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
BACKGROUND: Plakophilins (PKPs) are widely involved in gene transcription, translation, and signal transduction, playing a crucial role in tumorigenesis and progression. However, the function and potential mechanism of PKP1/2/3 in ovarian cancer (OC) remains unclear. It’s of great value to explore t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568375/ https://www.ncbi.nlm.nih.gov/pubmed/33088217 http://dx.doi.org/10.1186/s12935-020-01602-3 |
_version_ | 1783596506297663488 |
---|---|
author | Gao, Lingling Li, Xiao Guo, Qian Nie, Xin Hao, Yingying Liu, Qing Liu, Juanjuan Zhu, Liancheng Yan, Limei Lin, Bei |
author_facet | Gao, Lingling Li, Xiao Guo, Qian Nie, Xin Hao, Yingying Liu, Qing Liu, Juanjuan Zhu, Liancheng Yan, Limei Lin, Bei |
author_sort | Gao, Lingling |
collection | PubMed |
description | BACKGROUND: Plakophilins (PKPs) are widely involved in gene transcription, translation, and signal transduction, playing a crucial role in tumorigenesis and progression. However, the function and potential mechanism of PKP1/2/3 in ovarian cancer (OC) remains unclear. It’s of great value to explore the expression and prognostic values of PKP1/2/3 and their potential mechanisms, immune infiltration in OC. METHODS: The expression levels, prognostic values and genetic variations of PKP1/2/3 in OC were explored by various bioinformatics tools and databases, and PKP2/3 were selected for further analyzing their regulation network and immune infiltration. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) enrichment were also conducted. Finally, the expression and prognosis of PKP2 were validated by immunohistochemistry. RESULTS: The expression level and prognosis of PKP1 showed little significance in ovarian cancer, and the expression of PKP2/3 mRNA and protein were upregulated in OC, showing significant correlations with poor prognosis of OC. Functional enrichment analysis showed that PKP2/3 and their correlated genes were significantly enriched in adaptive immune response, cytokine receptor activity, organization of cell–cell junction and extracellular matrix; KEGG analysis showed that PKP2/3 and their significantly correlated genes were involved in signaling pathways including cytokine-mediated signaling pathway, receptor signaling pathway and pathways in cancer. Moreover, PKP2/3 were correlated with lymphocytes and immunomodulators. We confirmed that high expression of PKP2 was significantly associated with advanced stage, poor differentiation and poor prognosis of OC patients. CONCLUSION: Members of plakophilins family showed various degrees of abnormal expressions and prognostic values in ovarian cancer. PKP2/3 played crucial roles in tumorigenesis, aggressiveness, malignant biological behavior and immune infiltration of OC, and can be regarded as potential biomarker for early diagnosis and prognosis evaluation in OC. |
format | Online Article Text |
id | pubmed-7568375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75683752020-10-20 Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments Gao, Lingling Li, Xiao Guo, Qian Nie, Xin Hao, Yingying Liu, Qing Liu, Juanjuan Zhu, Liancheng Yan, Limei Lin, Bei Cancer Cell Int Primary Research BACKGROUND: Plakophilins (PKPs) are widely involved in gene transcription, translation, and signal transduction, playing a crucial role in tumorigenesis and progression. However, the function and potential mechanism of PKP1/2/3 in ovarian cancer (OC) remains unclear. It’s of great value to explore the expression and prognostic values of PKP1/2/3 and their potential mechanisms, immune infiltration in OC. METHODS: The expression levels, prognostic values and genetic variations of PKP1/2/3 in OC were explored by various bioinformatics tools and databases, and PKP2/3 were selected for further analyzing their regulation network and immune infiltration. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) enrichment were also conducted. Finally, the expression and prognosis of PKP2 were validated by immunohistochemistry. RESULTS: The expression level and prognosis of PKP1 showed little significance in ovarian cancer, and the expression of PKP2/3 mRNA and protein were upregulated in OC, showing significant correlations with poor prognosis of OC. Functional enrichment analysis showed that PKP2/3 and their correlated genes were significantly enriched in adaptive immune response, cytokine receptor activity, organization of cell–cell junction and extracellular matrix; KEGG analysis showed that PKP2/3 and their significantly correlated genes were involved in signaling pathways including cytokine-mediated signaling pathway, receptor signaling pathway and pathways in cancer. Moreover, PKP2/3 were correlated with lymphocytes and immunomodulators. We confirmed that high expression of PKP2 was significantly associated with advanced stage, poor differentiation and poor prognosis of OC patients. CONCLUSION: Members of plakophilins family showed various degrees of abnormal expressions and prognostic values in ovarian cancer. PKP2/3 played crucial roles in tumorigenesis, aggressiveness, malignant biological behavior and immune infiltration of OC, and can be regarded as potential biomarker for early diagnosis and prognosis evaluation in OC. BioMed Central 2020-10-17 /pmc/articles/PMC7568375/ /pubmed/33088217 http://dx.doi.org/10.1186/s12935-020-01602-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Gao, Lingling Li, Xiao Guo, Qian Nie, Xin Hao, Yingying Liu, Qing Liu, Juanjuan Zhu, Liancheng Yan, Limei Lin, Bei Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments |
title | Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments |
title_full | Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments |
title_fullStr | Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments |
title_full_unstemmed | Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments |
title_short | Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments |
title_sort | identification of pkp 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568375/ https://www.ncbi.nlm.nih.gov/pubmed/33088217 http://dx.doi.org/10.1186/s12935-020-01602-3 |
work_keys_str_mv | AT gaolingling identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT lixiao identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT guoqian identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT niexin identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT haoyingying identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT liuqing identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT liujuanjuan identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT zhuliancheng identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT yanlimei identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments AT linbei identificationofpkp23aspotentialbiomarkersofovariancancerbasedonbioinformaticsandexperiments |